Advances in development of rechargeable mitochondrial antioxidants

Progress in Molecular Biology and Translational Science

Volumn 127, Issue , 2014, Pages 251-265

  Lukashev, Alexander N ^a,b   Skulachev, Maxim V ^a   Ostapenko, Victoria ^a   Savchenko, Alla Yu ^c   Pavshintsev, V V ^a   Skulachev, Vladimir P ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b CHUMAKOV INSTITUTE OF POLIOMYELITIS AND VIRAL ENCEPHALITIDES   (Russian Federation)

^c I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Dry eye syndrome; Mitochondria targeted antioxidants; Oxidative stress; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; RECHARGEABLE MITOCHONDRIAL ANTIOXIDANT; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN;

ARTICLE; DEGENERATIVE DISEASE; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; EYE DISEASE; GROWTH, DEVELOPMENT AND AGING DISORDERS; HUMAN; INFLAMMATION; LIVER PROTECTION; NONHUMAN; PRIORITY JOURNAL; AGING; ANIMAL; CHEMISTRY; DISEASES; DRUG EFFECTS; LIVER; METABOLISM; MITOCHONDRION; PATHOLOGY;

AGING; ANIMALS; ANTIOXIDANTS; DISEASE; HUMANS; LIVER; MITOCHONDRIA; UNCOUPLING AGENTS;

EID: 84906669906     PISSN: 18771173     EISSN: 18780814     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394625-6.00010-6     Document Type: Chapter

References (54)

1. V.P. Skulachev Cationic antioxidants as a powerful tool against mitochondrial oxidative stress Biochem Biophys Res Commun 441 2013 275 279
2. J. Grundlingh, P.I. Dargan, M. El-Zanfaly, and D.M. Wood 2,4-Dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death J Med Toxicol 7 2011 205 212
3. L.E. Rosenberg, W.A. Fenton, A.L. Horwich, F. Kalousek, and J.P. Kraus Targeting of nuclear-encoded proteins to the mitochondrial matrix: implications for human genetic defects Ann N Y Acad Sci 488 1986 99 108
4. N.M. Sakhrani, and H. Padh Organelle targeting: third level of drug targeting Drug Des Devel Ther 7 2013 585 599
5. E.A. Liberman, V.P. Topaly, L.M. Tsofina, A.A. Jasaitis, and V.P. Skulachev Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria Nature 222 1969 1076 1078
6. L.E. Bakeeva, L.L. Grinius, and A.A. Jasaitis et al. Conversion of biomembrane-produced energy into electric form. II. Intact mitochondria Biochim Biophys Acta 216 1970 13 21
7. K. Zhao, G.M. Zhao, and D. Wu et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury J Biol Chem 279 2004 34682 34690 (Pubitemid 39318098)
8. D.B. Zorov, C.R. Filburn, L.O. Klotz, J.L. Zweier, and S.J. Sollott Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes J Exp Med 192 2000 1001 1014
9. G.F. Kelso, C.M. Porteous, and C.V. Coulter et al. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties J Biol Chem 276 2001 4588 4596
10. Y.N. Antonenko, A.V. Avetisyan, and L.E. Bakeeva et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies Biochemistry (Mosc) 73 2008 1273 1287
11. V.J. Adlam, J.C. Harrison, and C.M. Porteous et al. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury FASEB J 19 2005 1088 1095 (Pubitemid 40946434)
12. E.Y. Plotnikov, D.N. Silachev, and A.A. Chupyrkina et al. New-generation Skulachev ions exhibiting nephroprotective and neuroprotective properties Biochemistry (Mosc) 75 2010 145 150
13. L.E. Bakeeva, I.V. Barskov, and M.V. Egorov et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke) Biochemistry (Mosc) 73 2008 1288 1299
14. V.P. Skulachev, V.N. Anisimov, and Y.N. Antonenko et al. An attempt to prevent senescence: a mitochondrial approach Biochim Biophys Acta 1787 2009 437 461
15. V.P. Skulachev, and V.D. Longo Aging as a mitochondria-mediated atavistic program: can aging be switched off? Ann N Y Acad Sci 1057 2005 145 164 (Pubitemid 43211632)
16. V.N. Anisimov, L.E. Bakeeva, and P.A. Egormin et al. Mitochondria- targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 5. SkQ1 prolongs lifespan and prevents development of traits of senescence Biochemistry (Mosc) 73 2008 1329 1342
17. A.V. Krementsova, N.V. Roshina, E.A. Tsybul'ko, O.Y. Rybina, A.V. Symonenko, and E.G. Pasyukova Reproducible effects of the mitochondria-targeted plastoquinone derivative SkQ1 on Drosophila melanogaster lifespan under different experimental scenarios Biogerontology 13 2012 595 607
18. M.V. Skulachev, Y.N. Antonenko, and V.N. Anisimov et al. Mitochondrial-targeted plastoquinone derivatives. Effect on senescence and acute age-related pathologies Curr Drug Targets 12 2011 800 826
19. V.N. Anisimov, M.V. Egorov, and M.S. Krasilshchikova et al. Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents Aging (Albany NY) 3 2011 1110 1119
20. N.G. Kolosova, N.A. Stefanova, N.A. Muraleva, and V.P. Skulachev The mitochondria-targeted antioxidant SkQ1 but not N-acetylcysteine reverses aging-related biomarkers in rats Aging (Albany NY) 4 2012 686 694
21. V.V. Neroev, M.M. Archipova, and L.E. Bakeeva et al. Mitochondria- targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals Biochemistry (Mosc) 73 2008 1317 1328
22. B.K. Chacko, A. Srivastava, and M.S. Johnson et al. Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis Hepatology 54 2011 153 163
23. D.A. Lowes, B.M. Thottakam, N.R. Webster, M.P. Murphy, and H.F. Galley The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis Free Radic Biol Med 45 2008 1559 1565
24. E.J. Gane, F. Weilert, and D.W. Orr et al. The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients Liver Int 30 2010 1019 1026
25. J.S. Au, and P.J. Pockros Novel therapeutic approaches for hepatitis C Clin Pharmacol Ther 95 2014 78 88
26. M. Pelletier, T.S. Lepow, L.K. Billingham, M.P. Murphy, and R.M. Siegel New tricks from an old dog: mitochondrial redox signaling in cellular inflammation Semin Immunol 24 2012 384 392
27. I.N. Shipounova, D.A. Svinareva, and T.V. Petrova et al. Reactive oxygen species produced in mitochondria are involved in age-dependent changes of hematopoietic and mesenchymal progenitor cells in mice. A study with the novel mitochondria-targeted antioxidant SkQ1 Mech Ageing Dev 131 2010 415 421
28. Y. Yang, S. Karakhanova, S. Soltek, J. Werner, P.P. Philippov, and A.V. Bazhin In vivo immunoregulatory properties of the novel mitochondria-targeted antioxidant SkQ1 Mol Immunol 52 2012 19 29
29. E.Y. Plotnikov, M.A. Morosanova, and I.B. Pevzner et al. Protective effect of mitochondria-targeted antioxidants in an acute bacterial infection Proc Natl Acad Sci U S A 110 2013 E3100 E3108
30. I.A. Demianenko, T.V. Vasilieva, and L.V. Domnina et al. Novel mitochondria-targeted antioxidants, "Skulachev-ion" derivatives, accelerate dermal wound healing in animals Biochemistry (Mosc) 75 2010 274 280
31. V.P. Romashchenko, I.I. Galkin, and V.V. Zakharova et al. Mitochondria-targeted compounds decrease TNF-α-dependent endothelium activation FEBS J 280 Suppl 1 2013 246
32. J. Tschopp, and K. Schroder NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10 2010 210 215
33. A. Dashdorj, K.R. Jyothi, and S. Lim et al. Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines BMC Med 11 2013 178
34. P. Mao, M. Manczak, U.P. Shirendeb, and P.H. Reddy MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis Biochim Biophys Acta 2013 1832 2322 2331
35. D.A. Lowes, N.R. Webster, M.P. Murphy, and H.F. Galley Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis Br J Anaesth 110 2013 472 480
36. R.K. Chaturvedi, and M.F. Beal Mitochondrial approaches for neuroprotection Ann N Y Acad Sci 1147 2008 395 412
37. V.P. Skulachev Mitochondria-targeted antioxidants as promising drugs for treatment of age-related brain diseases J Alzheimers Dis 28 2012 283 289
38. L. Pagani, and A. Eckert Amyloid-beta interaction with mitochondria Int J Alzheimers Dis 2011 2011 925050
39. N.A. Kapay, O.V. Popova, and N.K. Isaev et al. Mitochondria-targeted plastoquinone antioxidant SkQ1 prevents amyloid-beta-induced impairment of long-term potentiation in rat hippocampal slices J Alzheimers Dis 36 2013 377 383
40. M.J. McManus, M.P. Murphy, and J.L. Franklin The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease J Neurosci 31 2011 15703 15715
41. N.A. Stefanova, N.A. Muraleva, V.P. Skulachev, and N.G. Kolosova Alzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1 J Alzheimers Dis 38 2014 681 694
42. R.K. Chaturvedi, and M.F. Beal Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases Mol Cell Neurosci 55 2013 101 114
43. B.J. Snow, F.L. Rolfe, and M.M. Lockhart et al. A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease Mov Disord 25 2010 1670 1674
44. A. Federico, E. Cardaioli, P. Da Pozzo, P. Formichi, G.N. Gallus, and E. Radi Mitochondria, oxidative stress and neurodegeneration J Neurol Sci 322 2012 254 262
45. M.E. Gurney, H. Pu, and A.Y. Chiu et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation Science 264 1994 1772 1775 (Pubitemid 24227760)
46. E. Miquel, A. Cassina, and L. Martinez-Palma et al. Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis Free Radic Biol Med 70 2014 204 213
47. J.W. Miller, J. Le Couter, E.C. Strauss, and N. Ferrara Vascular endothelial growth factor a in intraocular vascular disease Ophthalmology 120 2013 106 114
48. D.A. Tsarev, R.S. Zverev, E.M. Kazmina, V.N. Tashlitsky, and V.P. Skulachev Evaluating the stability of a cationic plastoquinone derivative (PDTP) in visomitin eye drops Pharm Chem J 47 2013 219 224
49. E.V. Yani, L.A. Katargina, and N.B. Chesnokova et al. The first experience of using the drug Vizomitin in the treatment of "dry eyes" Pract Med 4 2012 134 137
50. R.A. Smith, C.M. Porteous, C.V. Coulter, and M.P. Murphy Selective targeting of an antioxidant to mitochondria Eur J Biochem 263 1999 709 716 (Pubitemid 29361943)
51. I.I. Severina, F.F. Severin, and G.A. Korshunova et al. In search of novel highly active mitochondria-targeted antioxidants: thymoquinone and its cationic derivatives FEBS Lett 587 2013 2018 2024
52. S.S. Korshunov, V.P. Skulachev, and A.A. Starkov High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria FEBS Lett 416 1997 15 18 (Pubitemid 27470791)
53. F.F. Severin, I.I. Severina, and Y.N. Antonenko et al. Penetrating cation/fatty acid anion pair as a mitochondria-targeted protonophore Proc Natl Acad Sci U S A 107 2010 663 668
54. E.Y. Plotnikov, D.N. Silachev, and S.S. Jankauskas et al. Mild uncoupling of respiration and phosphorylation as a mechanism providing nephro- and neuroprotective effects of penetrating cations of the SkQ family Biochemistry (Mosc) 77 2012 1029 1037